Bumper Offer - Urjas oil Just @ Rs. 1
Furabit is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Urinary Tract Infection. Secondary and off-label uses of Furabit have also been mentioned below.
The right dosage of Furabit depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Furabit can also lead to other problems, which have been listed below. Usually, these side effects of Furabit go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furabit's effect during pregnancy is Safe and Moderate while nursing. It is important to know if Furabit has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Furabit related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Anemia, Liver Disease must refrain from the use of Furabit since this can cause severe adverse effects. Some other conditions that can be affected by Furabit are listed in the contraindications section below.
Drug interactions for Furabit have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Furabit is considered not safe while driving, and is not addictive.
Furabit is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Furabit is used -
Severe
Moderate
Mild
Is the use of Furabit safe for pregnant women?
Pregnant women can take Furabit safely.
Is the use of Furabit safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Furabit. Immediately discontinue Furabit if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Furabit on the Kidneys?
Furabit may have mild side effects on the kidneys.
What is the effect of Furabit on the Liver?
Side effects of Furabit rarely affect the liver.
What is the effect of Furabit on the Heart?
Very few cases of side effects of Furabit on the heart have been reported.
Furabit should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Furabit unless your doctor advises you to do so -
Is this Furabit habit forming or addictive?
No, there is no any evidence that Furabit is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Furabit can make you feel drowsy.
Is it safe?
Yes, but consume Furabit only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Furabit for mental disorders.
Interaction between Food and Furabit
You can take Furabit with food.
Interaction between Alcohol and Furabit
Taking Furabit with alcohol has not been seen to have harmful effects. However, please be careful if you do so.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915